Recombinant Carbonic Anhydrase IX Antibody / CA9
CAIX is localized along the brush border of the pars convoluta and pars recta segments of the proximal tubule, as well as focally along the luminal surface of Bowman's capsule adjoining the outgoing proximal tubule. Reportedly, CAIX is expressed by 93% of primary and 84% of metastatic renal cell carcinomas. This MAb may be useful in the investigations of carcinomas of proximal nephrogenic differentiation especially those showing tubular differentiation.
Product Specifications
CAS Number
9000-83-3
Specifications
Immunohistochemistry (FFPE) : 1-2 µg/mL, Western blot: 2-4 µg/mL
UniProt
Q16790
Host
Rabbit
Reactivity
Human
Immunogen
The extracellular N-terminal proteoglycan-like region was used as the immunogen for the recombinant Carbonic Anhydrase IX antibody.
Clonality
Recombinant Monoclonal
Isotype
IgG κ
Clone
CA9/9621R
Type
Recombinant
Applications
IHC-P, WB
Purity
Protein A/G affinity
Format
Purified
Buffer
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Reconstitution
Aliquot the recombinant Carbonic Anhydrase IX antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This recombinant Carbonic Anhydrase IX antibody is available for research use only.
Storage Conditions
Aliquot the recombinant Carbonic Anhydrase IX antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05% sodium azide
Applications Notes
Optimal dilution of the recombinant Carbonic Anhydrase IX antibody should be determined by the researcher.
Location
Cell membrane, Nucleus
Image Legend
Documents
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MMP9 (MMP9/2025R), CF640R conjugate, 0.1mg/mL
